Skip to main content

Table 3 Efficacy of lncRNAs or circRNAs in the differential diagnosis of pancreatic cancer from healthy participants

From: Advances in biomarkers and techniques for pancreatic cancer diagnosis

Study Markers source Diagnostic power
AUC Sensitivity (%) Specificity (%)
lncRNAs
Guo et al SNHG15 Serum 0.727 68.3 89.6
Li et al Linc-pint Plasma 0.87 87.5 77.1
Linc-pint + CA19-9 Plasma 0.92 85.9 82.9
circRNAs
Yang et al circ-LDLRAD3 + CA19-9 plasma 0.87 80.33 93.55